Cargando…
Comparative effectiveness of torasemide versus furosemide in symptomatic therapy in heart failure patients: Preliminary results from the randomized TORNADO trial
BACKGROUND: Recent reports suggest that torasemide might be more beneficial than furosemide in patients with symptomatic heart failure (HF). The aim was to compare the effects of torasemide and furosemide on clinical outcomes in HF patients. METHODS: This study pilot consisted of data from the ongoi...
Autores principales: | Balsam, Paweł, Ozierański, Krzysztof, Marchel, Michał, Gawałko, Monika, Niedziela, Łukasz, Tymińska, Agata, Sieradzki, Bartosz, Sieradzki, Maciej, Fojt, Anna, Bakuła, Elwira, Główczyńska, Renata, Peller, Michał, Markulis, Maciej, Bednarski, Janusz, Kowalik, Robert, Cacko, Andrzej, Niewiński, Grzegorz, Filipiak, Krzysztof J., Opolski, Grzegorz, Grabowski, Marcin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083045/ https://www.ncbi.nlm.nih.gov/pubmed/31909470 http://dx.doi.org/10.5603/CJ.a2019.0114 |
Ejemplares similares
-
The impact of torasemide on haemodynamic and neurohormonal stress, and cardiac remodelling in heart failure – TORNADO: a study protocol for a randomized controlled trial
por: Balsam, Paweł, et al.
Publicado: (2017) -
Association of Galectin-3 and Soluble ST2, and Their Changes, with Echocardiographic Parameters and Development of Heart Failure after ST-Segment Elevation Myocardial Infarction
por: Tymińska, Agata, et al.
Publicado: (2019) -
OCULUS study: Virtual reality-based education in daily clinical practice
por: Balsam, Paweł, et al.
Publicado: (2019) -
Novel biochemical predictors of unfavorable prognosis for stable coronary disease
por: Cacko, Andrzej, et al.
Publicado: (2018) -
Clinical characteristics and thromboembolic risk of atrial fibrillation patients with and without congestive heart failure. Results from the CRATF study
por: Balsam, Paweł, et al.
Publicado: (2018)